mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.08 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.09 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |